New study compares provisional and two-stent strategies for coronary bifurcation lesionsOctober 30, 2013
SAN FRANCISCO, CA - OCTOBER 30, 2013 - A new clinical trial shows that a two-stent technique for treatment of bifurcation lesions with a large stenotic side branch was not associated with significant improved outcomes compared to a provisional stenting approach. The findings from the Nordic-Baltic Bifurcation IV study were presented today at the 25th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored by the Cardiovascular Research Foundation (CRF), TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine.
Coronary bifurcation lesions are caused from a build-up of plaque in the heart at a location where one artery branches from another. In provisional side branch stenting, the main vessel branch is stented and the side branch only if compromised. Currently, provisional side branch stenting is the preferred strategy for treatment of bifurcation lesions.
The safety and effectiveness of provisional stenting for bifurcations that involve a large side branch of the coronary arteries is unknown. The Nordic-Baltic IV trial was a randomized, controlled, non-blinded, multicenter, superiority trial that compared provisional stenting with a two-stent strategy for the treatment of coronary bifurcation lesions involving a major side branch.
The primary endpoint was the composite of major adverse cardiac events (MACE) including cardiac death, non-procedure-related myocardial infarction, target vessel revascularization and stent thrombosis after six months. Follow up is planned until five years. A total of 450 patients with coronary bifurcation lesions were randomized 1:1 to the provisional strategy (stenting of the main vessel and provisional stenting of the side branch) or a complex two-stent strategy (planned stenting of both the main vessel and the side branch).
After six months, the MACE rate was not significantly different between provisional and two-stent techniques (4.6 percent and 1.8 percent, respectively, p=0.09). Individual endpoints were also similar between the two techniques including total death (0 and 0.4 percent, p=0.32), non-procedural myocardial infarction (1.8 percent and 0.9 percent, p=0.50) and target vessel revascularization (3.7 percent and 1.3 percent, p=0.11). There were no incidents of cardiac death in either group.
However, in contrast to prior studies, longer and more complex procedures in the two-stent group did not translate into more procedural myocardial infarctions.
"Results of this trial indicate that a two-stent technique does not significantly improve mid-term outcomes for patients with bifurcation lesions compared to provisional stenting," said lead investigator Indulis Kumsars, MD. Dr. Kumsars is Head of the Cardiac Catheterization Laboratory at the Latvian Cardiology Center in Riga, Latvia.
Given the fact that there was a weak trend towards lower MACE in the two stent strategy and follow up is continuing for five years, the Nordic-Baltic investigators concluded, "Recommendations on optimal strategies for this lesion subset should await longer term follow up."
About CRF and TCT
The Cardiovascular Research Foundation (CRF) is an independent, academically focused nonprofit organization dedicated to improving the survival and quality of life for people with cardiovascular disease through research and education. Since its inception in 1991, CRF has played a major role in realizing dramatic improvements in the lives of countless numbers of patients by establishing the safe use of new technologies and therapies in interventional cardiovascular medicine. CRF is the sponsor of the Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Celebrating its 25th anniversary this year, TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine. For more information, visit http://www.crf.org and http://www.tctconference.com.
Cardiovascular Research Foundation
Related Cardiac Death Articles:
Older adults with COPD who recently started using opioids have an increased risk of coronary artery disease-related death compared to non-opioid users, researchers at St.
A new report presents 10 quality and performance measures that are intended to help stakeholders--including health systems, legislative bodies, and nongovernmental organizations, as well as healthcare practitioners, patients, families and communities -- in the effort to prevent sudden cardiac death.
The sudden death of a 13-year-old boy resulted in more than 20 relatives to be incorrectly diagnosed as having a potentially lethal heart rhythm condition.
The risk of sudden cardiac death was significantly greater in patients with thyroid hormone levels at the higher end of normal, compared to patients with levels at the low end.
Researchers from Emory's Rollins School of Public Health developed a sudden cardiac death (SCD) predictive model that can help identify and prevent the disease in individuals at high risk.
For the first time, a team of researchers led by Rajat Deo, MD, MTR, an assistant professor of Cardiovascular Medicine in the Perelman School of Medicine at the University of Pennsylvania, has developed and validated a prediction model to determine sudden cardiac death risk in adults without a history of cardiovascular disease (CVD).
One in nine men may be at higher risk of premature death due to sudden cardiac death - usually with no warning.
Sudden deaths in young, seemingly healthy competitive athletes are tragic events.
Genetic testing has shed new light on the deaths of nearly 500 young Australians and New Zealanders who died from sudden cardiac death in a three-year period, the New England Journal of Medicine reports today.
A research team has developed a non-invasive 3-D virtual heart to help doctors determine who faces the highest risk of a life-threatening arrhythmia and would benefit from a defibrillator implant.
Related Cardiac Death Reading:
One Beat at a Time - Living with Sudden Cardiac Death
by Matthew D. Noble (Author)
Not many twenty eight years olds have enough life experiences to write an entertaining autobiography. Matthew D. Noble could have written three by now. Born in 1976 with an abnormal heart, he spent his formative years literally wondering if his next heartbeat would be his last. He escaped sudden cardiac death five times before the age of 18, amazing when you consider that over 95% of people who have an episode like Matthew’s don’t survive. How did he survive five? This book details the miraculous stories of how two nurses; a gym teacher, an implantable defibrillator (ICD) and an... View Details
Clinical Approach to Sudden Cardiac Death Syndromes
by Josep Brugada (Adapter), Pedro Brugada (Adapter), Ramon Brugada (Adapter)
Clinical cardiologists are encountering an important challenge in the caring of families with inherited cardiac diseases. The majority of the inherited cardiac diseases causing sudden death express themselves at variable ages in the form of altered muscle function (i.e hypertrophic or dilated cardiomyopathy) or in the form of arrhythmias (i.e. Brugada syndrome, long QT syndrome). However, it is not uncommon that the first sign of the disease may actually be sudden cardiac death, even before the identification of clear clinical abnormalities. In this last decade, with more than 50 new... View Details
Sudden Cardiac Death in the Young and Athletes: Text Atlas of Pathology and Clinical Correlates
by Gaetano Thiene (Author), Domenico Corrado (Author), Cristina Basso (Author)
This text atlas focuses on the pathology and molecular genetics of sudden cardiac death in the young and in athletes, presenting the state of the art in the field as the basis for development and implementation of more effective prevention strategies, including, ultimately, molecular therapy that will cure the underlying biological defect. A wealth of high-resolution color images, accompanied by clear supporting text, are presented to document the anatomic pathology of the cardiac diseases most frequently responsible for sudden cardiac death in this population, including coronary artery... View Details
Open Heart: A Cardiac Surgeon’s Stories of Life and Death on the Operating Table
by Stephen Westaby (Author)
In gripping prose, one of the world's leading cardiac surgeons lays bare both the wonder and the horror of a life spent a heartbeat away from death
When Stephen Westaby witnessed a patient die on the table during open-heart surgery for the first time, he was struck by the quiet, determined way the surgeons walked away. As he soon understood, this detachment is a crucial survival strategy in a profession where death is only a heartbeat away. In Open Heart, Westaby reflects on over 11,000 surgeries, showing us why the procedures have never become routine and will never be. With... View Details
Cardiac Arrhythmias, Pacing and Sudden Death (Cardiovascular Medicine)
by Peter Kowey (Editor), Jonathan P. Piccini (Editor), Gerald Naccarelli (Editor), James A. Reiffel (Editor)
This book provides up-to-date, user-friendly and comprehensive guidance on the evaluation, diagnosis, and medical and surgical treatment of cardiac arrhythmias. This ensures that that this title aids every trainee and practicising cardiologist, cardiac electrophysiologist, cardiac surgeon, vascular surgeon, diabetologist, cardiac radiologist and any physician who manages cardiac patients.
Cardiovascular Medicine: Cardiac Arrhythmias, Pacing and Sudden Death covers every aspect of cardiac arrhythmias, from cardiac signs and symptoms through imaging and the genetic basis... View Details
Paul Zoll MD; The Pioneer Whose Discoveries Prevent Sudden Death
by Stafford I. Cohen (Author)
Paul Zoll MD is an engaging account of the life and work of Dr. Paul M. Zoll, the physician and medical researcher behind the treatments and techniques we use today to save victims of heart attacks and to prevent premature deaths from other forms of heart failure. The book tells how one man's compassion, insight, intelligence and perseverance solved medical mysteries that had plagued people through the ages. The biography also shows the human dimensions of Dr. Zoll, including his childhood, education, military service, family relationships, recreational interests and social associations... View Details
Organ Donation and Transplantation after Cardiac Death
by David Talbot (Editor), Anthony D'Alessandro (Editor)
With the success of organ transplantation and the declining number of heart beating cadaver doctors, the number of patients awaiting a transplant continues to rise. This means that alternative sources of donors have been sought, including donors after cardiac death. Such donors sustain rapid damage to their organs due to ischaemia, and as a consequence, some organs do not work initially and some none at all. The proportion of such transplants has increased dramatically in recent years--25% of kidney transplants in the UK were from such donors in 2006, highlighting how much progress has been... View Details
by Hubert F. Baars (Editor), Pieter A. F. M. Doevendans (Editor), Arjan C. Houweling (Editor), J. Peter van Tintelen (Editor)
Clinical management and signs are the focus of this practical cardiogenetic reference for those who are involved in the care for cardiac patients with a genetic disease. With detailed discussion of the basic science of cardiogenetics in order to assist in the clinical understanding of the topic.
The genetic causes of various cardiovascular diseases are explained in a concise clinical way that reinforces the current management doctrine in a practical manner.
The authors will cover the principles of molecular genetics in general but also specific to cardiac... View Details
Erasing Death: The Science That Is Rewriting the Boundaries Between Life and Death
by Sam Parnia (Author), Josh Young (Author)
Erasing Death: The Science That Is Rewriting the Boundaries Between Life and Death reveals that death is not a moment in time. Death, rather, is a process—a process that can be interrupted well after it has begun. Innovative techniques have proven to be effective in revitalizing both the body and mind, but they are only employed in approximately half of the hospitals throughout the United States and Europe.
Dr. Sam Parnia, Director of the AWARE Study (AWAreness during REsuscitation) and one of the world’s leading experts on the scientific study of death and... View Details
Preventing Sudden Death in Sport & Physical Activity
by Douglas J. Casa (Author), Rebecca L. Stearns (Author)
5 Stars! Doody's Review Service!
(1st Edition Review)
Preventing Sudden Death in Sport and Physical Activity, Second Edition examines the etiology, prevention, recognition, treatment, and return-to-play protocol of the common causes of sudden death in sport. Chapters are written by content area experts, offering a blend of clinical, scientific, and research expertise regarding each medical condition that is discussed.
Sudden death on the field is a growing concern in sports and physical activity. This groundbreaking text arms readers with the knowledge and skills they need to... View Details